Your institution may have access to this item. Find your institution then sign in to continue.
Title
DKK1 as a novel target for myeloma immunotherapy.
Authors
Qian, Jianfei; Yi, Qing
Abstract
Novel, potent tumor-associated antigens are needed to improve the efficacy of immunotherapy for myeloma. We demonstrated that active vaccination using the DKK1-DNA vaccine in the myeloma mouse model protected mice from developing myeloma and effectively treated established myeloma. Therefore, DKK1 could be developed as a novel vaccine for myeloma immunotherapy.